Y Cadroy
Overview
Explore the profile of Y Cadroy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cadroy Y, Boneu B
Arch Mal Coeur Vaiss
. 2002 Jan;
94(11 Suppl):1220-4.
PMID: 11794962
Thrombosis is a multifactorial pathology. In addition to the environmental factors, there are genetic components which either predispose or protect against its occurrence. Some are common to only a small...
2.
Cadroy Y, Sakariassen K, Charlet J, Thalamas C, Boneu B, Sie P
Blood
. 2001 Nov;
98(10):3159-61.
PMID: 11698306
This study investigates whether the polymorphisms of 3 important platelet receptors affected experimental thrombus formation in men. Forty healthy male volunteers randomly recruited were genotyped for the variable number of...
3.
Sakariassen K, Hanson S, Cadroy Y
Thromb Res
. 2001 Oct;
104(3):149-74.
PMID: 11672758
The purpose of the present communication is to evaluate the importance of blood flow and surface reactivity for measurement of antithrombotic drug activity or efficacy in selected model systems of...
4.
Cadroy Y, Sakariassen K, Grandjean H, Thalamas C, Boneu B, Sie P
Thromb Haemost
. 2001 Jul;
85(6):1097-103.
PMID: 11434691
A number of studies have reported conflicting data on the association of the PlA1/PlA2 polymorphism of the GPIIIa gene and coronary syndromes. We have investigated the effect of this polymorphism...
5.
Cadroy Y, Bossavy J, Thalamas C, Sagnard L, Sakariassen K, Boneu B
Circulation
. 2000 Jun;
101(24):2823-8.
PMID: 10859288
Background: We conducted a double-blind, randomized, crossover study to assess the antithrombotic effects of the combination of aspirin (acetylsalicylic acid, ASA) and clopidogrel, with or without a loading dose, versus...
6.
Cadroy Y, Dupouy D, Boneu B, Plaisancie H
J Immunol
. 2000 Mar;
164(7):3822-8.
PMID: 10725743
To determine whether polymorphonuclear leukocytes (PMN) modulate the production of tissue factor (TF) by monocytes, PBMC were incubated with increasing concentrations of PMN. PMN did not express any procoagulant activity....
7.
Bossavy J, Sakariassen K, Thalamas C, Boneu B, Cadroy Y
Arterioscler Thromb Vasc Biol
. 1999 Sep;
19(9):2269-75.
PMID: 10479672
Thrombin is a main mediator of arterial thrombus formation, and its inhibition is an important antithrombotic strategy. However, the place of vitamin K antagonists among the different therapeutic strategies for...
8.
Bossavy J, Cadroy Y, Sakariassen K, Boneu B, Barret A
Ann Vasc Surg
. 1999 Jul;
13(4):393-401.
PMID: 10398736
The effect of nonfractionated heparin on the formation and composition of arterial thrombus is unclear. The purpose of this study in a human ex vivo model was to analyze fibrinoplatelet...
9.
Bossavy J, Sakariassen K, Rubsamen K, Thalamas C, Boneu B, Cadroy Y
Arterioscler Thromb Vasc Biol
. 1999 May;
19(5):1348-53.
PMID: 10323789
Polyethylene glycol (PEG)-hirudin is a derivative of hirudin with a long plasma half-life. We have compared the efficacy of PEG-hirudin with unfractionated heparin (UH) in preventing arterial thrombosis. Arterial thrombus...
10.
Bossavy J, Thalamas C, Sagnard L, Barret A, Sakariassen K, Boneu B, et al.
Blood
. 1998 Aug;
92(5):1518-25.
PMID: 9716578
No randomized study comparing the effect of combined ticlopidine and aspirin therapy versus each drug alone in reducing poststenting thrombotic complications has been performed. To compare these three antiplatelet regimens...